Variation in antibiotic use in neonatal intensive care units in the Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1270-1275

  Yves Liem, T B ^a   Krediet, Tannette G ^a   Fleer, André ^b   Egberts, Toine C G ^a   Rademaker, Carin M A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotic consumption; Neonates; NICUs

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; FLUCLOXACILLIN; GENTAMICIN; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CONSENSUS; DRUG USE; DRUG UTILIZATION; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGITIS; MONOTHERAPY; NECROTIZING ENTEROCOLITIS; NETHERLANDS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PHARMACEUTICAL CARE; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; NETHERLANDS;

EID: 77953558608     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq107     Document Type: Article

References (35)

1. Du W, Warrier I, Tutag Lehr V et al. Changing patterns of drug utilization in a neonatal intensive care population. Am J Perinatol 2006; 23: 279-85.
2. Fonseca SN, Ehrenkranz RA, Baltimore RS. Epidemiology of antibiotic use in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1994; 15: 156-62.
3. Gortner L. Drug utilisation in preterm and term neonates. Pharmacoeconomics 1993; 4: 437-45.
4. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL et al. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 2005; 24: 766-73.
5. Lesko SM, Epstein MF, Mitchell AA. Recent patterns of drug use in newborn intensive care. J Pediatr 1990; 116: 985-90.
6. Warrier I, Du W, Natarajan G et al. Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol 2006; 46: 449-55.
7. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3.
8. Kuster SP, Ruef C, Ledergerber B et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection 2008; 36:549-59.
9. Bizzarro MJ, Gallagher PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol 2007; 31: 26-32.
10. Vander Stichele RH, Elseviers MM, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.
11. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment. http://www.whocc.no/atcddd/ (2 February 2010, date last accessed).
12. Bergman U, Popa C, Tomson Y et al. Drug utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113-8.
13. Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother 2008; 61: 743-5.
14. Bradley JS, Nelson JD. Nelson's Pocket Book of Pediatric Antimicrobial Therapy. ElK Grove Village, USA: American Academy of Pediatrics, 2009.
15. Paediatric Formulary Committee. BNF for Children 2009. London: BMJ Group, RPS Publishing and RCPCH Publications, 2009.
16. SWAB. NethMap 2009-Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria in the Netherlands. Bilthoven, Netherlands: RIVM, 2009.
17. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
18. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24: 699-706.
19. Lemmen SW, Becker G, Frank U et al. Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. Scand J Infect Dis 2001; 33: 219-21.
20. Metjian TA, Prasad PA, Kogon A et al. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 2008; 27: 106-11.
21. Ruttimann S, Keck B, Hartmeier C et al. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis 2004; 38: 348-56.
22. De Man P, Verhoeven BA, Verbrugh HA et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973-8.
23. Ding H, Yang Y, Lu Q et al. Five-year surveillance of antimicrobial use in Chinese pediatric intensive care units. J Trop Pediatr 2008; 54: 238-42.
24. Ding H, Yang Y, Chen Y et al. Antimicrobial usage in paediatric intensive care units in China. Acta Paediatr 2008; 97: 100-4.
25. Ding H, Yang Y, Wei J et al. Influencing the use of antibiotics in a Chinese pediatric intensive care unit. Pharm World Sci 2008; 30: 787-93.
26. Potocki M, Goette J, Szucs TD et al. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription. Infection 2003; 31: 398-403.
27. Zhang W, Liu X, Wang Y et al. Antibiotic use in pulmonology wards of Chinese children's hospitals: 2002-2006. J Clin Pharm Ther 2009; 34: 61-5.
28. Pakyz AL, Gurgle HE, Ibrahim OM et al. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol 2009; 30: 600-3.
29. Palcevski G, Ahel V, Vlahovic-Palcevski V et al. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol Drug Saf 2004; 13: 181-5.
30. Zhang W, Shen X, Bergman U et al. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children's hospitals (2002-2006). Int J Antimicrob Agents 2008; 32: 250-5.
31. Zhang W, Shen X, Wang Y et al. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf 2008; 17: 306-11.
32. Zhang W, Shen X, Wang Y et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals. Eur J Clin Pharmacol 2008; 64: 821-8.
33. Hajdu A, Samodova OV, Carlsson TR et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect 2007; 66: 378-84.
34. Polk RE, Fox C, Mahoney A et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44: 664-70.
35. Bennet R, Eriksson M, Fant H. Estimating exposure to antimicrobial agents in a pediatric hospital ward, controlling for patient weight and waste of unused drug. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2006. American Society for Microbiology, Washington, DC, USA, Abstract K-1413.